USD 0.62
(-5.56%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -10.23 Million | -3.08 Million | -2.06 Million | -1.71 Million | -382.88 Thousand | -1.2 Million |
Net Income | -8.16 Million | -3.13 Million | -8.15 Million | -1.6 Million | -918.21 Thousand | -1.56 Million |
Depreciation & Amortization | 2040.17 | 2850.47 | 4364.11 | 1996.08 | 2005.78 | 1330.36 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 937.3 Thousand | 396.6 Thousand | 1.52 Million | 487.27 Thousand | - | - |
Change in working capital | -121.9 Thousand | -40.73 Thousand | -48.75 Thousand | -512.63 Thousand | 509.94 Thousand | 328.27 Thousand |
Other non-cash items | -1.24 Million | 230.19 Thousand | 6.14 Million | 476.6 Thousand | 10.36 Thousand | 38.4 Thousand |
Investing Cash Flow | - | - | 324.94 | -12.82 Thousand | -2329.67 | - |
Investments in PPE | - | - | - | -12.82 Thousand | -2329.67 | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 324.94 | - | - | - |
Financing Cash Flow | 9.43 Million | 3.15 Million | 2.85 Million | 1.85 Million | 367.84 Thousand | 1.18 Million |
Debt repayment | - | -604.4 Thousand | - | -49.1 Thousand | - | -15.61 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 9.43 Million | 3.75 Million | 2.85 Million | 2.16 Million | - | 1.16 Million |
Other Financing Activities | -516.74 Thousand | -166.63 Thousand | -182.23 Thousand | -255.34 Thousand | 367.84 Thousand | - |
Accounts receivables | -712.32 Thousand | -135.08 Thousand | -6630.76 | -71.74 Thousand | 17.03 Thousand | -3266.95 |
Accounts payables | 814.4 Thousand | 225.91 Thousand | -13.41 Thousand | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 590.41 Thousand | 94.35 Thousand | -42.12 Thousand | -440.89 Thousand | 492.91 Thousand | 331.53 Thousand |
Cash at beginning of period | 940.64 Thousand | 930.28 Thousand | 140.71 Thousand | 5735.88 | 21.93 Thousand | 47.39 Thousand |
Cash at end of period | 163.24 Thousand | 940.64 Thousand | 930.28 Thousand | 140.71 Thousand | 5735.88 | 21.93 Thousand |
Capital Expenditure | - | - | - | -12.82 Thousand | -2329.67 | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -777.39 Thousand | 10.35 Thousand | 789.57 Thousand | 134.97 Thousand | -16.19 Thousand | -25.45 Thousand |
Free Cash Flow | -10.23 Million | -3.08 Million | -2.06 Million | -1.72 Million | -385.21 Thousand | -1.2 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -5.49 Million | -1.66 Million | -1.88 Million | -8.16 Million | -4.03 Million | -2.53 Million |
Depreciation & Amortization | 474.00 | 349.91 | 510.04 | 2040.17 | 676.00 | 676.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 678.72 Thousand | - | 12.87 Thousand | 937.3 Thousand | 44.08 Thousand | 824.31 Thousand |
Change in working capital | 1.19 Million | 1.28 Million | -760.27 Thousand | -121.9 Thousand | 1.15 Million | -969.3 Thousand |
Other non-cash items | -2.79 Million | -1.09 Million | -995.14 Thousand | -1.24 Million | -555.46 Thousand | -274.9 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 24.28 Million | 1.54 Million | 4.21 Million | 9.43 Million | 2.41 Million | 2.62 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 22.64 Million | 1.54 Million | 4.21 Million | 9.43 Million | 2.45 Million | 3.1 Million |
Other Financing Activities | -459.12 Thousand | 2 Million | -167.65 Thousand | -516.74 Thousand | -33.58 Thousand | -486.12 Thousand |
Accounts receivables | -543.05 Thousand | 320.49 Thousand | -542.89 Thousand | -712.32 Thousand | -91.14 Thousand | 75.56 Thousand |
Accounts payables | 1.77 Million | 1.13 Million | -184.42 Thousand | 814.4 Thousand | 1.07 Million | -839.87 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -31.68 Thousand | 959.6 Thousand | -217.37 Thousand | 590.41 Thousand | 942.1 Thousand | -806.81 Thousand |
Cash at beginning of period | 736.17 Thousand | 163.24 Thousand | 132 Thousand | 940.64 Thousand | 1.14 Million | 1.47 Million |
Cash at end of period | 18.61 Million | 543.44 Thousand | 163.24 Thousand | 163.24 Thousand | 179.32 Thousand | 1.14 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 17.87 Million | 380.19 Thousand | 31.24 Thousand | -777.39 Thousand | -970.66 Thousand | -326.15 Thousand |
Free Cash Flow | -6.41 Million | -1.16 Million | -4.18 Million | -10.23 Million | -3.38 Million | -2.95 Million |
PDYNW
SUMICHEM
000225
BNGRF
002630
AKVA